"The James Gynecologic Oncology Mill Run provides outpatient supportive services for patients with ovarian, cervical, endometrial, vulvar and vaginal cancers. The James Gynecologic Oncology Mill Run includes a subspecialized multidisciplinary team of gynecologic oncology experts is dedicated to providing the best and most targeted gynecologic cancer treatment for each patient. Our genetic- and molecular-based research helps us understand each patient's unique cancer and develop and deliver the most effective targeted therapy that leads to better outcomes, fewer side effects and more hope."

During the past decade, OSU Gynecologic Oncology at Mill Run conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "OSU Gynecologic Oncology at Mill Run" are "Breast Cancer" (1 trials), "Low-grade Serous Fallopian Tube Cancer" (1 trials), "Low-grade Serous Ovarian Cancer" (1 trials) and "Low-grade Serous Peritoneal Cancer" (1 trials). Many other conditions were trialed in "OSU Gynecologic Oncology at Mill Run" in a lesser frequency.

Most popular intervention types in "OSU Gynecologic Oncology at Mill Run" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alpelisib" (1 trials), "Fulvestrant" (1 trials), "Gedatolisib" (1 trials), "MEK162, MEK inhibitor; oral" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "OSU Gynecologic Oncology at Mill Run" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "OSU Gynecologic Oncology at Mill Run". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in OSU Gynecologic Oncology at Mill Run, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in OSU Gynecologic Oncology at Mill Run, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".